Tower Research Capital LLC (Trc) Evogene Ltd. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $3,405 - $6,039	-4,541 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.09 - $1.83 $3,994 - $6,706	-3,665 Reduced 44.66%	4,541 $6,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $2.83 $13,375 - $23,222	8,206 New	8,206 $13,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $3.45 $2,234 - $3,146	-912 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.3 - $5.02 $3,009 - $4,578	912 New	912 $3,000
Q1 2021 May 17, 2021	SELL	$4.29 - $9.94 $4,886 - $11,321	-1,139 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.41 - $5.63 $1,180 - $2,758	490 Added 75.5%	1,139 $5,000
Q3 2020 Nov 16, 2020	BUY	$0.97 - $4.08 $629 - $2,647	649 New	649 $3,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $66.7M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.